Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: Different effects on different parameters

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 7, Issue 2, 2002, Pages 95-107

  Jugdutt, Bodh I ^a   Menon, Vijayan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Amlodipine; Collagen; Enalapril; Shape; Wall stress; Wall thickness

Indexed keywords

AMLODIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PLACEBO; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ECHOCARDIOGRAPHY; HEALING; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFUSION; HEART VENTRICLE REMODELING; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STUNNED HEART MUSCLE; THICKNESS; ANIMAL; DISEASE MODEL; HEART; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART VOLUME; HEMODYNAMICS; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; SCAR; TIME; WOUND HEALING;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CARDIAC VOLUME; CICATRIX; COLLAGEN; DISEASE MODELS, ANIMAL; DOGS; ENALAPRIL; HEART; HEMODYNAMIC PROCESSES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; ORGAN SIZE; TIME FACTORS; VENTRICULAR REMODELING; WOUND HEALING;

EID: 0036017517     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840200700206     Document Type: Article

References (75)

1. Healing after myocardial infarction in the dog: Changes in infarct hydroxyproline and topography
2. Myocardial infarct expansion
3. Deterring myocardial infarct expansion
4. Ventricular remodelling after myocardial infarction
5. Prevention of ventricular remodelling post myocardial infarction: Timing and duration of therapy
6. Regional cardiac dilation after acute myocardial infarction: Recognition by two-dimensional echocardiography
7. Late effects of acute infarct dilation on heart size. A two-dimensional Echocardiographic study
8. Cellular mechanisms of myocardial infarct expansion
9. Identification of patients prone to infarct expansion by the degree of regional shape distortion on an early two-dimensional echocardiogram after myocardial infarction. A prospective study
10. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors
11. The speed of healing of myocardial infarction: A study of the pathologic anatomy in 72 cases
12. The histopathologic evolution of myocardial infarction
13. Remodeling and reparation of the cardiovascular system
14. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications
15. Treatment of patients with symptomless LV dysfunction after MI
16. Effect of captopril on progressive ventricular dilatation after anterior MI
17. Prevention of ventricular remodeling after myocardial infarction and in congestive heart failure
18. Detection of viability of dysfunctional myocardium in coronary heart disease. II. Echocardiography
19. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril
20. Role of infarction expansion in rupture of the ventricular septum after acute myocardial infarction. A two-dimensional Echocardiographic study
21. Exercise training after anterior Q wave myocardial infarction: Importance of regional left ventricular function and topography
22. Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post-infarction pericarditis. Influence of other pharmacologic agents during early remodeling
23. Effect of long-term captopril therapy on left ventricular remodeling and function during healing and canine myocardial infarction
24. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate
25. Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on remodeling, function, mass and collagen
26. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model
27. Effect of reperfusion on ventricular mass, topography and function during healing of anterior infarction
28. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
29. Prompt improvement of left ventricular function and topography with combined reperfusion and intravenous nitroglycerin in acute myocardial infarction
30. The stunned myocardium: Prolonged, postischemic ventricular dysfunction
31. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage
32. Deleterious effects of oxygen radicals in ischemia/reperfusion: Resolved and unresolved issues
33. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium
34. The "no-reflow" phenomenon after temporary coronary occlusion in the dog
35. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in the dog
36. Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease
37. Ultrastructural assessment of myocardial necrosis occurring during ischemia and 3-h reperfusion in the dog
38. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials
39. Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Systematic overview of individual data from 100,000 patients in randomized trials
40. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The Healing and Afterload Reducing Therapy Trial
41. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
42. Effect of ACE inhibition on infarct collagen deposition and remodeling during healing after transmural canine myocardial infarction
43. Angiotensin I converting enzyme inhibitors and cardiac remodeling
44. Contribution of the kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors
45. Ramiprilat enhances endothelial autocoid formation by inhibiting breakdown of endothelium-derived bradykinin
46. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
47. Effects of amlodipine versus enalapril on left ventricular remodelling after reperfused anterior myocardial canine infarction
48. Opposite effects of amlodipine and enalapril on infarct collagen and remodelling during healing after reperfused myocardial infarction
49. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction
50. Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts
51. Biphasic survival response to amlodipine after myocardial infarction in rats: Association with cardiac vascular remodeling
52. Amlodipine releases nitric oxide from canine coronary microvessels. An unexpected mechanism of action of a calcium channel-blocking agent
53. Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts
54. Functional impact on remodeling during healing after non-Q-wave versus Q-wave anterior myocardial infarction in the dog
55. Elastic properties of the myocardium: A quantitative approach with physiological and clinical applications
56. Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog
57. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline
58. Rate of collagen deposition during healing after myocardial infarction in the rat and dog models: Mechanistic insights into ventricular remodeling
59. Intravenous nitroglycerin unloading in acute myocardial infarction
60. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog
61. Comparative effects of vasodilator drugs on flow distribution and venous return
62. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage
63. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model
64. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis
65. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril
66. Limitation of left ventricular hypertrophy by ACE inhibition after anterior Q-wave myocardial infarction
67. Effects of combination angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltrate and myocardial interstitial fibrosis after acute myocardial infarction
68. The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload
69. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs
70. Calcium channel blockers in acute myocardial infarction and unstable angina pectoris: An overview
71. Effects of amlodipine, a long-acting dihdropyridine calcium antagonist in aging hypertension: Pharmacodynamics in relation to disposition
72. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production
73. Delayed effects of early infarct-limiting therapies on healing
74. Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning
75. Cardiac remodeling - Concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling